A research observed that mice treated with the S1P antagonist Fingolimod (FTY720) to prevent lymphocyte migration into the lungs before initial infection with Bordetella pertussis were significantly more severely affected in the later stages of infection. This evidence concerns the gene MBTPS1 and infection.